QNCX
USDQuince Therapeutics Inc. Common Stock
$1.600+0.040 (2.564%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.560
High
$1.620
Low
$1.555
Volume
0.11M
Company Fundamentals
Market Cap
85.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.27M
Exchange
NMS
Currency
USD
52-Week Range
Low $0.72Current $1.600High $2.45
Related News
BusinessWire
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the poster presentation of
View more
Analyst Upgrades
D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target
D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics with a Buy and maintains $4 price target.
View more
BusinessWire
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study
Quince Therapeutics, Inc.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.